Log In
BCIQ
Print this Print this
 

Hyzaar, losartan/hydrochlorothiazide

  Manage Alerts
Collapse Summary General Information
Company Merck & Co. Inc.
DescriptionCombination of losartan angiotensin II receptor antagonist and hydrochlorothiazide diuretic
Molecular Target Angiotensin II type 1 (AT1) receptor (AGTR1)
Mechanism of ActionAngiotensin II type 1 (AT1) receptor antagonist
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentMarketed
Standard IndicationHypertension
Indication DetailsTreat severe hypertension
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today